zinc finger protein 204, pseudogeneGenealiases: []
Q-omics provides the consensus-scored ZNF204P profile across patient tissues and cancer cell-line models. ZNF204P expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, ZNF204P is differentially expressed in 12, with the highest sampling consensus in KIRC. Additionally, ZNF204P RNA expression shows 18,640 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, and THYM as cancer lineages where ZNF204P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ZNF204P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ZNF204P survival associations across molecular data types. ZNF204P RNA expression shows survival associations in the most cancer types (21), followed by mutation status (5). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ZNF204P RNA expression–survival associations across cancer types. High ZNF204P expression shows unfavorable associations in STAD and LGG, but favorable associations in KIRC, UVM, OV and SKCM. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for ZNF204P RNA expression.
This table summarizes ZNF204P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for ZNF204P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ZNF204P shows lower tumor expression in KIRC, THCA, KIRP, LUAD, COAD and KICH. The KIRC box plot shows higher ZNF204P RNA expression in normal versus tumor tissue (log2 FC = −1.488, t-test p < 0.001).
This table shows molecular features associated with ZNF204P in patient tissues and cancer cell lines. In patient samples, ZNF204P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set. In cancer cell lines, ZNF204P RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LUNG_NSCLC_LUAD, while CRISPR and shRNA rows add functional-dependency signals in NCI60_ALL.
